You just read:

Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer

News provided by

Inovio Pharmaceuticals, Inc.

Jun 26, 2019, 09:11 ET